Green technologies: DBT explores commercial use of bioprocess engineering

The bioscientists in India who are working in the areas of biosystems and bioprocess engineering can send their research proposals on creating commercially viable green technologies to department of biotechnology by May 15, 2015

green

Bridging Gaps: The current need is to overcome the constraints involved in large scale production processes with focus towards clean and green technology

As per DBT, it has initiated a new program on Biosystems and Bioprocess engineering to promote integration of fundamental knowledge between engineering and biological science to find innovative and efficient solutions for the development and improvement of sustainable bioprocesses of commercial interest. The current need is to overcome the constraints involved in large scale production processes with focus towards clean and green technology. The endeavor would be to support interdisciplinary approaches for developing translational research oriented
projects in this area.

Proposals: The research and development proposals have been invited in the various areas of Biotransformation and Enzyme Engineering. These include application of enzyme or whole cell as a biocatalyst for the production of industrially important specialty/ bulk chemicals; Design of enzymes for specific applications such as biotransformation, drug discovery, diagnostic tests, biosensors or any other commercially significant applications; Host and Metabolic Engineering: Manipulation of hosts such as bacteria, fungi, animal and insect cells for the production of small molecules, proteins, enzymes, biosimilars, vaccines, etc. Apart from that the proposals could also be in metabolic engineering of organisms to produce commercially important chemicals and biochemicals. Under Biosystems Engineering, there can be research ideas including model-based design of bioprocesses leading to new sustainable production processes, systems-level approaches to optimization of bioprocess/bioprocess plant with advanced design, analysis and optimization tools, integrated bioprocess development, developing advanced monitoring and control for bioprocesses, process analytical techniques and quality based design of bioprocesses.

Eligibility: Scientists working in the Universities/Academic Institutions/National Laboratories and NonProfit Organizations, with sound scientific backgrounds and relevant publications in proposed area. The proposal should be preferably developed on network mode involving two or more institutes. Inclusion of industrial partner with involvement in the work will be considered as an advantage; Specific role of the industry with possible contribution (financial/ in-kind contribution) must be provided. The proof of concept, preliminary results, available leads and quantifiable targets should be clearly defined (proposals should not include screening and isolation of micro-organisms).

Selection: The mode of selection includes the system of sending proposals by the interested researchers which would be received and screened by constituted expert committee for consideration for financial support. Short-listed proposals would be further screened by Task Force. Proposals may be submitted online in the DBT's R & D format through eProMIS (http://dbtepromis.nic.in/Login.aspx) under Category of Area-‘Biosystems & Bioprocess Engineering' clearly stating ‘proposal against Call for Proposal'as mentioned in DBT format. Last Date of submission is May 15, 2015.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Entries Open for Social Entrepreneur of the Year (SEOY)-India Award 2017

Tuesday, 28 Mar 2017   |   Jubilant Bhartia Foundation

Business Wire India The Schwab Foundation for Social Entrepreneurship, a sister organization of the

Latest clinical research confirms that IQOS reduces smoker exposure to

Monday, 27 Mar 2017   |   Philip Morris International

Business Wire India Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today announces

China's Healthcare Market to See Surge of Investment and Opportunities

Monday, 27 Mar 2017   |   Reed Sinopharm Exhibitions

Business Wire India Last October, the Chinese government approved a blueprint called “Healthy China

BusinessWire India.com - Pharmaceutical

Bwi-logo

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity

Tuesday, 21 Mar 2017   |   Masimo

Business Wire India Masimo (NASDAQ: MASI) announced the CE marking of noninvasive blood pressure (NIBP)

BusinessWire India.com - Medical Devices

Bwi-logo

Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity

Tuesday, 21 Mar 2017   |   Masimo

Business Wire India Masimo (NASDAQ: MASI) announced the CE marking of noninvasive blood pressure (NIBP)

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X